adverse events

Backed by €15 million in EU funding, the Ubiquitous Pharmacogenomics Consortium seeks to implement preemptive testing at seven healthcare systems by 2020.

Slow Report

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

An international team detected a variant associated with anthracycline-induced cardiotoxicity in a study of more than 450 children treated with the drug.

The study provides a public list of ADRs ranked by severity and highlights the efficacy of crowd-sourcing for pharmacovigilance studies.

NEW YORK (GenomeWeb News) – HemoShear today announced a partnership with Expression Analysis to develop a database for evaluating the vascular pharmacology of new drug compounds.

The International Severe Adverse Event Consortium will collaborate with CHI's Center for Translational Research to identify genetic markers for adverse drug reactions.

The iSAEC this week announced a partnership with Shanghai Jaio Tong University to study serious drug reactions in Chinese populations, expanding the group's understanding of the impact of ethnic diversity on genomically influenced adverse events with a strong immunological underpinning.

The goal of the partnership is to increase knowledge of the impact of ethnic diversity on the genetics of drug-induced serious adverse events.

The consortium and the network will collaborate to identify genetic traits for adverse drug reactions.

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.